Erik Jensen, MD, MSCE
Adjunct Assistant Professor of Pediatrics (Neonatology & Newborn Services)
Co-Director, Inpatient Infant Chronic Lung Disease Program, Lucile Packard Children's Hospital
Department: Pediatrics
Contact information
Lucile Packard Children's Hospital
725 Welch Rd
Stanford, CA 94304
725 Welch Rd
Stanford, CA 94304
Office: 215-590-1653
Fax: 215-590-8831
Fax: 215-590-8831
Education:
BA (Chemistry)
Pomona College, 2003.
MD
University of Washington School of Medicine, 2007.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2015.
Permanent linkBA (Chemistry)
Pomona College, 2003.
MD
University of Washington School of Medicine, 2007.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2015.
Description of Clinical Expertise
bronchopulmonary dysplasiaDescription of Research Expertise
Bronchopulmonary dysplasiaNeonatal epidemiology
Selected Publications
Jensen EA, Watterberg KL: Postnatal corticosteroids to prevent bronchopulmonary dysplasia. NeoReviews Nov 2023 Notes: In press.Wright CJ, McCulley DJ, Mitra S, Jensen EA: Acetaminophen for the patent ductus arteriosus: Has safety been adequately demonstrated? J Perinatol 43(10): 1230-1237, Oct 2023.
Nelin TD, Yang N, Radack J, Lorch SA, DeMauro SB, Bamat NA, Jensen EA, Gibbs K, Just AC, Burris HH: Associations of neighborhood social vulnerability with emergency department visits and readmissions among infants with bronchopulmonary dysplasia. J Perinatol Page: doi: 10.1038, Jul 2023 Notes: epub ahead of print.
Raffay TM, Jensen EA. : Can intermittent hypoxemia help detect pulmonary hypertension in high-risk preemies? Am J Respir Crit Care Med 207(7): 809-811, Apr 2023.
Jensen EA, Wiener LE, Rysavy MA, Dysart KC, Gantz MG, Eichenwald EC, Greenberg RG, Harmon HM, Laughon MM, Watterberg KL, Walsh MC, Yoder BA, Lorch SA, DeMauro SB for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.: Assessment of corticosteroid therapy and death or disability according to pretreatment risk of death or bronchopulmonary dysplasia in extremely preterm infants. JAMA Netw Open 6(5): e2312277, 2023.
Gentle SJ, Rysavy MA, Li L, Laughon MM, Patel RM, Jensen EA, Hintz S, Ambalavanan N, Carlo WA, Watterberg K; National Institute of Child Health and Human Development Neonatal Research Network: Heterogeneity of treatment effects of hydrocortisone by risk of bronchopulmonary dysplasia or death among extremely preterm infants in the National Institute of Child Health and Human Development Neonatal Research Network trial: A secondary analysis of a randomized clinical trial. JAMA Netw Open 6(5): e2315315, 2023.
Bancalari E, Claure N, Jensen EA, Jobe A. : Definitions and Diagnostic Criteria of Bronchopulmonary Dysplasia: Clinical and Research Implications. The Newborn Lung. 4th Edition. Bancalari E, Keszler M, Davis PG (eds.). Elsevier, 2023 Notes: Chapter 13.
Vitale JL, DeMauro SB, Gibbs K, Jensen EA: Clinician Opinions on Nasal versus Oral Intubation in Infants with Bronchopulmonary Dysplasia. Pediatric Academic Societies Annual Meeting, Washington, DC. 2023 Notes: Platform presentation.
McCooty K, Bamat N, Gibbs K, DeMauro S, Jensen EA: Rescue systemic corticosteroid therapy for severe respiratory failure in bronchopulmonary dysplasia. Pediatric Academic Societies Annual Meeting, Washington, DC 2023 Notes: Platform Presentation.
Tsukahara K, Johnson B, Klimowich K, Chiotos K, Jensen EA, Planet P, Phinizy P, Piccione J: Comparison of tracheal aspirate and bronchoalveolar lavage samples in the microbiological diagnosis of lower respiratory tract infection in pediatric patients. Pediatr Pulmonol 57(10): 2405-10, Jul 2022.